Literature DB >> 22552204

Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device.

Martin H J Wiesen1, Fedja Farowski, Markus Feldkötter, Bernd Hoppe, Carsten Müller.   

Abstract

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for simultaneous quantification of mycophenolic acid (MPA) and its phenolic glucuronide (MPAG) in saliva and plasma. Saliva was collected and processed using a standardized commercially available collection device. Sample preparation comprised of protein precipitation with acetonitrile and subsequent centrifugation, followed by evaporation and reconstitution with mobile phase. A labeled isotope of MPA was used as internal standard, and chromatographic separation was achieved on a C18 column with an isocratic flow. LC-MS/MS detection was performed using a triple-stage quadrupole mass spectrometer working in selected reaction monitoring mode with positive electrospray ionization (ESI). The analytes were quantified in a single run within 2 min. For saliva, linearity was demonstrated over the concentration range of 5.0 to 400.0 ng/ml for both MPA and MPAG, and from 0.08 to 20.00 μg/ml for MPA and 0.4 to 100.0 μg/ml for MPAG in plasma. The lower limits of quantification for MPA and MPAG were 0.07 and 0.80 ng/ml in saliva, and 0.002 and 0.009 μg/ml in plasma, respectively. Inter- and intra-day precisions expressed as relative standard deviation (RSD) and accuracies were less than 15%. The recoveries for MPA and MPAG from the collection device's swab were higher than 90%. Sample stability was confirmed for bench times up to 24 h at room temperature. The method was validated according to International Conference on Harmonization (ICH) guidelines Q2 (R1) Validation of Analytical Procedures. The applicability of the method was tested in a renal pediatric patient. Based on a limited sampling strategy, MPA saliva and plasma concentrations were found in good agreement with each other. We suggest that the described method is suitable to analyze saliva and plasma samples of small volumes for therapeutic drug monitoring (TDM) and pharmacokinetic studies in pediatric patients.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552204     DOI: 10.1016/j.chroma.2012.04.008

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  Investigation of the Association Between Total and Free Plasma and Saliva Mycophenolic Acid Concentrations Following Administration of Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients.

Authors:  Emily Brooks; Susan E Tett; Nicole M Isbel; Brett McWhinney; Christine E Staatz
Journal:  Clin Drug Investig       Date:  2019-12       Impact factor: 2.859

Review 2.  Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.

Authors:  Mwlod Ghareeb; Fatemeh Akhlaghi
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

3.  Tacrolimus Concentration in Saliva of Kidney Transplant Recipients: Factors Influencing the Relationship with Whole Blood Concentrations.

Authors:  Mwlod Ghareeb; Reginald Y Gohh; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

Review 4.  Mass spectrometry as a tool for studying autism spectrum disorder.

Authors:  Alisa G Woods; Armand G Ngounou Wetie; Izabela Sokolowska; Stefanie Russell; Jeanne P Ryan; Tanja Maria Michel; Johannes Thome; Costel C Darie
Journal:  J Mol Psychiatry       Date:  2013-05-21

5.  Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry.

Authors:  Vivek Upadhyay; Vikas Trivedi; Gaurang Shah; Manish Yadav; Pranav S Shrivastav
Journal:  J Pharm Anal       Date:  2013-06-12

6.  Saliva as Blood Alternative in Therapeutic Monitoring of Teriflunomide-Development and Validation of the Novel Analytical Method.

Authors:  Bartłomiej Sankowski; Sylwia Michorowska; Emilia Raćkowska; Mariusz Sikora; Joanna Giebułtowicz
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

Review 7.  Recent Advances in Therapeutic Drug Monitoring of Voriconazole, Mycophenolic Acid, and Vancomycin: A Literature Review of Pediatric Studies.

Authors:  Matylda Resztak; Joanna Sobiak; Andrzej Czyrski
Journal:  Pharmaceutics       Date:  2021-11-23       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.